HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-FEB-17 5UVC TITLE DESIGN, SYNTHESIS, AND EVALUATION OF THE FIRST SELECTIVE AND POTENT G- TITLE 2 PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) INHIBITOR FOR THE POTENTIAL TITLE 3 TREATMENT OF HEART FAILURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-ADRENERGIC RECEPTOR KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 23-538; COMPND 5 SYNONYM: BETA-ARK-1,G-PROTEIN COUPLED RECEPTOR KINASE 2; COMPND 6 EC: 2.7.11.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GRK2, ADRBK1, BARK, BARK1; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS KINASE, INHIBITOR, HEART FAILURE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.D.HOFFMAN,J.D.LAWSON REVDAT 3 06-MAR-24 5UVC 1 REMARK REVDAT 2 06-SEP-17 5UVC 1 JRNL REVDAT 1 26-JUL-17 5UVC 0 JRNL AUTH T.OKAWA,Y.ARAMAKI,M.YAMAMOTO,T.KOBAYASHI,S.FUKUMOTO, JRNL AUTH 2 Y.TOYODA,T.HENTA,A.HATA,S.IKEDA,M.KANEKO,I.D.HOFFMAN, JRNL AUTH 3 B.C.SANG,H.ZOU,T.KAWAMOTO JRNL TITL DESIGN, SYNTHESIS, AND EVALUATION OF THE HIGHLY SELECTIVE JRNL TITL 2 AND POTENT G-PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) JRNL TITL 3 INHIBITOR FOR THE POTENTIAL TREATMENT OF HEART FAILURE. JRNL REF J. MED. CHEM. V. 60 6942 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28699740 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00443 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 17607 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 948 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.72 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1201 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.19 REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3736 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.98000 REMARK 3 B22 (A**2) : 0.98000 REMARK 3 B33 (A**2) : -1.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.762 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.328 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.261 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 26.176 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3862 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3674 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5194 ; 0.986 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8467 ; 0.759 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 453 ; 6.112 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 189 ;33.602 ;23.386 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 705 ;14.988 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;16.085 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 548 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4276 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 909 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 30 A 602 REMARK 3 ORIGIN FOR THE GROUP (A): 7.1271 27.4056 11.7203 REMARK 3 T TENSOR REMARK 3 T11: 0.1728 T22: 0.0475 REMARK 3 T33: 0.2431 T12: -0.0208 REMARK 3 T13: 0.0012 T23: -0.0457 REMARK 3 L TENSOR REMARK 3 L11: 1.6911 L22: 0.7158 REMARK 3 L33: 3.0168 L12: 0.3918 REMARK 3 L13: 0.5772 L23: 0.2312 REMARK 3 S TENSOR REMARK 3 S11: 0.0856 S12: -0.1351 S13: 0.1920 REMARK 3 S21: 0.0810 S22: -0.1321 S23: 0.0176 REMARK 3 S31: -0.4816 S32: 0.0883 S33: 0.0465 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5UVC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226523. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18606 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.52400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG MME 2000, 100MM MES PH 5.9, REMARK 280 17.5MM AMMONIUM SULFATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 273K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 56.57850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 56.57850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 47.71350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 56.57850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 56.57850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 47.71350 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 56.57850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.57850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 47.71350 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 56.57850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 56.57850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 47.71350 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 733 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 740 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 743 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 763 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -8 REMARK 465 SER A -7 REMARK 465 TYR A -6 REMARK 465 TYR A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 1 REMARK 465 ASP A 2 REMARK 465 TYR A 3 REMARK 465 ASP A 4 REMARK 465 ILE A 5 REMARK 465 PRO A 6 REMARK 465 THR A 7 REMARK 465 THR A 8 REMARK 465 GLU A 9 REMARK 465 ASN A 10 REMARK 465 LEU A 11 REMARK 465 TYR A 12 REMARK 465 PHE A 13 REMARK 465 GLN A 14 REMARK 465 GLY A 15 REMARK 465 ALA A 16 REMARK 465 MET A 17 REMARK 465 GLU A 18 REMARK 465 PRO A 19 REMARK 465 GLY A 20 REMARK 465 GLY A 21 REMARK 465 SER A 22 REMARK 465 THR A 23 REMARK 465 PRO A 24 REMARK 465 ALA A 25 REMARK 465 ALA A 26 REMARK 465 ARG A 27 REMARK 465 ALA A 28 REMARK 465 SER A 29 REMARK 465 THR A 97 REMARK 465 GLU A 98 REMARK 465 GLU A 99 REMARK 465 GLU A 100 REMARK 465 ARG A 101 REMARK 465 CYS A 120 REMARK 465 SER A 121 REMARK 465 HIS A 122 REMARK 465 PRO A 123 REMARK 465 PHE A 124 REMARK 465 SER A 125 REMARK 465 LYS A 126 REMARK 465 SER A 127 REMARK 465 ALA A 128 REMARK 465 THR A 129 REMARK 465 GLU A 130 REMARK 465 HIS A 131 REMARK 465 VAL A 132 REMARK 465 GLN A 133 REMARK 465 GLY A 134 REMARK 465 HIS A 135 REMARK 465 LEU A 136 REMARK 465 GLY A 137 REMARK 465 LYS A 138 REMARK 465 LYS A 139 REMARK 465 GLN A 140 REMARK 465 VAL A 141 REMARK 465 GLU A 476 REMARK 465 VAL A 477 REMARK 465 ASN A 478 REMARK 465 ALA A 479 REMARK 465 ALA A 480 REMARK 465 ASP A 481 REMARK 465 ALA A 482 REMARK 465 PHE A 483 REMARK 465 ASP A 484 REMARK 465 ILE A 485 REMARK 465 GLY A 486 REMARK 465 SER A 487 REMARK 465 PHE A 488 REMARK 465 ASP A 489 REMARK 465 GLU A 490 REMARK 465 GLU A 491 REMARK 465 ASP A 492 REMARK 465 THR A 493 REMARK 465 LYS A 494 REMARK 465 GLY A 495 REMARK 465 ILE A 496 REMARK 465 LYS A 497 REMARK 465 LEU A 498 REMARK 465 GLU A 537 REMARK 465 ALA A 538 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 194 -144.07 -110.77 REMARK 500 ASP A 250 73.11 56.90 REMARK 500 ARG A 316 -18.44 74.99 REMARK 500 ASP A 335 84.95 48.95 REMARK 500 ASP A 369 -145.71 -139.98 REMARK 500 LYS A 397 52.96 -109.68 REMARK 500 ASN A 508 -4.12 71.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8PV A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UUU RELATED DB: PDB DBREF 5UVC A 23 538 UNP P25098 ARBK1_HUMAN 23 538 SEQADV 5UVC MET A -8 UNP P25098 EXPRESSION TAG SEQADV 5UVC SER A -7 UNP P25098 EXPRESSION TAG SEQADV 5UVC TYR A -6 UNP P25098 EXPRESSION TAG SEQADV 5UVC TYR A -5 UNP P25098 EXPRESSION TAG SEQADV 5UVC HIS A -4 UNP P25098 EXPRESSION TAG SEQADV 5UVC HIS A -3 UNP P25098 EXPRESSION TAG SEQADV 5UVC HIS A -2 UNP P25098 EXPRESSION TAG SEQADV 5UVC HIS A -1 UNP P25098 EXPRESSION TAG SEQADV 5UVC HIS A 0 UNP P25098 EXPRESSION TAG SEQADV 5UVC HIS A 1 UNP P25098 EXPRESSION TAG SEQADV 5UVC ASP A 2 UNP P25098 EXPRESSION TAG SEQADV 5UVC TYR A 3 UNP P25098 EXPRESSION TAG SEQADV 5UVC ASP A 4 UNP P25098 EXPRESSION TAG SEQADV 5UVC ILE A 5 UNP P25098 EXPRESSION TAG SEQADV 5UVC PRO A 6 UNP P25098 EXPRESSION TAG SEQADV 5UVC THR A 7 UNP P25098 EXPRESSION TAG SEQADV 5UVC THR A 8 UNP P25098 EXPRESSION TAG SEQADV 5UVC GLU A 9 UNP P25098 EXPRESSION TAG SEQADV 5UVC ASN A 10 UNP P25098 EXPRESSION TAG SEQADV 5UVC LEU A 11 UNP P25098 EXPRESSION TAG SEQADV 5UVC TYR A 12 UNP P25098 EXPRESSION TAG SEQADV 5UVC PHE A 13 UNP P25098 EXPRESSION TAG SEQADV 5UVC GLN A 14 UNP P25098 EXPRESSION TAG SEQADV 5UVC GLY A 15 UNP P25098 EXPRESSION TAG SEQADV 5UVC ALA A 16 UNP P25098 EXPRESSION TAG SEQADV 5UVC MET A 17 UNP P25098 EXPRESSION TAG SEQADV 5UVC GLU A 18 UNP P25098 EXPRESSION TAG SEQADV 5UVC PRO A 19 UNP P25098 EXPRESSION TAG SEQADV 5UVC GLY A 20 UNP P25098 EXPRESSION TAG SEQADV 5UVC GLY A 21 UNP P25098 EXPRESSION TAG SEQADV 5UVC SER A 22 UNP P25098 EXPRESSION TAG SEQRES 1 A 547 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 547 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 A 547 GLU PRO GLY GLY SER THR PRO ALA ALA ARG ALA SER LYS SEQRES 4 A 547 LYS ILE LEU LEU PRO GLU PRO SER ILE ARG SER VAL MET SEQRES 5 A 547 GLN LYS TYR LEU GLU ASP ARG GLY GLU VAL THR PHE GLU SEQRES 6 A 547 LYS ILE PHE SER GLN LYS LEU GLY TYR LEU LEU PHE ARG SEQRES 7 A 547 ASP PHE CYS LEU ASN HIS LEU GLU GLU ALA ARG PRO LEU SEQRES 8 A 547 VAL GLU PHE TYR GLU GLU ILE LYS LYS TYR GLU LYS LEU SEQRES 9 A 547 GLU THR GLU GLU GLU ARG VAL ALA ARG SER ARG GLU ILE SEQRES 10 A 547 PHE ASP SER TYR ILE MET LYS GLU LEU LEU ALA CYS SER SEQRES 11 A 547 HIS PRO PHE SER LYS SER ALA THR GLU HIS VAL GLN GLY SEQRES 12 A 547 HIS LEU GLY LYS LYS GLN VAL PRO PRO ASP LEU PHE GLN SEQRES 13 A 547 PRO TYR ILE GLU GLU ILE CYS GLN ASN LEU ARG GLY ASP SEQRES 14 A 547 VAL PHE GLN LYS PHE ILE GLU SER ASP LYS PHE THR ARG SEQRES 15 A 547 PHE CYS GLN TRP LYS ASN VAL GLU LEU ASN ILE HIS LEU SEQRES 16 A 547 THR MET ASN ASP PHE SER VAL HIS ARG ILE ILE GLY ARG SEQRES 17 A 547 GLY GLY PHE GLY GLU VAL TYR GLY CYS ARG LYS ALA ASP SEQRES 18 A 547 THR GLY LYS MET TYR ALA MET LYS CYS LEU ASP LYS LYS SEQRES 19 A 547 ARG ILE LYS MET LYS GLN GLY GLU THR LEU ALA LEU ASN SEQRES 20 A 547 GLU ARG ILE MET LEU SER LEU VAL SER THR GLY ASP CYS SEQRES 21 A 547 PRO PHE ILE VAL CYS MET SER TYR ALA PHE HIS THR PRO SEQRES 22 A 547 ASP LYS LEU SER PHE ILE LEU ASP LEU MET ASN GLY GLY SEQRES 23 A 547 ASP LEU HIS TYR HIS LEU SER GLN HIS GLY VAL PHE SER SEQRES 24 A 547 GLU ALA ASP MET ARG PHE TYR ALA ALA GLU ILE ILE LEU SEQRES 25 A 547 GLY LEU GLU HIS MET HIS ASN ARG PHE VAL VAL TYR ARG SEQRES 26 A 547 ASP LEU LYS PRO ALA ASN ILE LEU LEU ASP GLU HIS GLY SEQRES 27 A 547 HIS VAL ARG ILE SER ASP LEU GLY LEU ALA CYS ASP PHE SEQRES 28 A 547 SER LYS LYS LYS PRO HIS ALA SER VAL GLY THR HIS GLY SEQRES 29 A 547 TYR MET ALA PRO GLU VAL LEU GLN LYS GLY VAL ALA TYR SEQRES 30 A 547 ASP SER SER ALA ASP TRP PHE SER LEU GLY CYS MET LEU SEQRES 31 A 547 PHE LYS LEU LEU ARG GLY HIS SER PRO PHE ARG GLN HIS SEQRES 32 A 547 LYS THR LYS ASP LYS HIS GLU ILE ASP ARG MET THR LEU SEQRES 33 A 547 THR MET ALA VAL GLU LEU PRO ASP SER PHE SER PRO GLU SEQRES 34 A 547 LEU ARG SER LEU LEU GLU GLY LEU LEU GLN ARG ASP VAL SEQRES 35 A 547 ASN ARG ARG LEU GLY CYS LEU GLY ARG GLY ALA GLN GLU SEQRES 36 A 547 VAL LYS GLU SER PRO PHE PHE ARG SER LEU ASP TRP GLN SEQRES 37 A 547 MET VAL PHE LEU GLN LYS TYR PRO PRO PRO LEU ILE PRO SEQRES 38 A 547 PRO ARG GLY GLU VAL ASN ALA ALA ASP ALA PHE ASP ILE SEQRES 39 A 547 GLY SER PHE ASP GLU GLU ASP THR LYS GLY ILE LYS LEU SEQRES 40 A 547 LEU ASP SER ASP GLN GLU LEU TYR ARG ASN PHE PRO LEU SEQRES 41 A 547 THR ILE SER GLU ARG TRP GLN GLN GLU VAL ALA GLU THR SEQRES 42 A 547 VAL PHE ASP THR ILE ASN ALA GLU THR ASP ARG LEU GLU SEQRES 43 A 547 ALA HET 8PV A 600 29 HET SO4 A 601 5 HET SO4 A 602 5 HETNAM 8PV N-BENZYL-3-({[5-(PYRIDIN-4-YL)-4H-1,2,4-TRIAZOL-3- HETNAM 2 8PV YL]METHYL}AMINO)BENZAMIDE HETNAM SO4 SULFATE ION FORMUL 2 8PV C22 H20 N6 O FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *72(H2 O) HELIX 1 AA1 GLU A 36 SER A 38 5 3 HELIX 2 AA2 ILE A 39 ARG A 50 1 12 HELIX 3 AA3 THR A 54 SER A 60 1 7 HELIX 4 AA4 GLN A 61 HIS A 75 1 15 HELIX 5 AA5 LEU A 76 GLU A 78 5 3 HELIX 6 AA6 ALA A 79 LYS A 94 1 16 HELIX 7 AA7 ALA A 103 TYR A 112 1 10 HELIX 8 AA8 TYR A 112 LEU A 118 1 7 HELIX 9 AA9 PHE A 146 GLY A 159 1 14 HELIX 10 AB1 GLY A 159 GLU A 167 1 9 HELIX 11 AB2 SER A 168 ASN A 183 1 16 HELIX 12 AB3 THR A 187 ASN A 189 5 3 HELIX 13 AB4 LYS A 224 GLN A 231 1 8 HELIX 14 AB5 GLY A 232 SER A 247 1 16 HELIX 15 AB6 ASP A 278 GLY A 287 1 10 HELIX 16 AB7 SER A 290 ARG A 311 1 22 HELIX 17 AB8 LYS A 319 ALA A 321 5 3 HELIX 18 AB9 ALA A 358 GLN A 363 1 6 HELIX 19 AC1 SER A 370 GLY A 387 1 18 HELIX 20 AC2 ASP A 398 MET A 409 1 12 HELIX 21 AC3 SER A 418 LEU A 429 1 12 HELIX 22 AC4 ASP A 432 ARG A 436 5 5 HELIX 23 AC5 GLY A 443 GLU A 449 1 7 HELIX 24 AC6 SER A 450 ARG A 454 5 5 HELIX 25 AC7 ASP A 457 GLN A 464 1 8 HELIX 26 AC8 ASP A 500 GLU A 504 1 5 HELIX 27 AC9 ILE A 513 VAL A 525 1 13 HELIX 28 AD1 VAL A 525 LEU A 536 1 12 SHEET 1 AA1 6 PHE A 191 ARG A 199 0 SHEET 2 AA1 6 GLY A 203 LYS A 210 -1 O VAL A 205 N ILE A 197 SHEET 3 AA1 6 MET A 216 ASP A 223 -1 O TYR A 217 N CYS A 208 SHEET 4 AA1 6 LYS A 266 LEU A 271 -1 O LEU A 271 N ALA A 218 SHEET 5 AA1 6 MET A 257 HIS A 262 -1 N TYR A 259 O ILE A 270 SHEET 6 AA1 6 LEU A 511 THR A 512 -1 O LEU A 511 N ALA A 260 SHEET 1 AA2 2 VAL A 313 VAL A 314 0 SHEET 2 AA2 2 CYS A 340 ASP A 341 -1 O CYS A 340 N VAL A 314 SHEET 1 AA3 2 ILE A 323 LEU A 325 0 SHEET 2 AA3 2 VAL A 331 ILE A 333 -1 O ARG A 332 N LEU A 324 SITE 1 AC1 10 ILE A 197 GLY A 200 PHE A 202 VAL A 205 SITE 2 AC1 10 ALA A 218 LYS A 220 ASP A 272 MET A 274 SITE 3 AC1 10 LEU A 324 ASP A 335 SITE 1 AC2 6 TYR A 356 LYS A 383 HIS A 388 SER A 389 SITE 2 AC2 6 ARG A 392 HOH A 724 SITE 1 AC3 2 HIS A 348 ALA A 349 CRYST1 113.157 113.157 95.427 90.00 90.00 90.00 P 42 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008837 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008837 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010479 0.00000